Clinical Trial Update: Safety and Efficacy of RESTEN-MP When Used in Conjunction With a Bare Metal Stent in Coronary Arteries [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the safety and efficacy of RESTEN-MP when used with a bare metal coronary stent in patients with coronary artery disease and restenosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Restenosis

Drugs mentioned

• RESTEN-MP

Snippet

Sponsor: Sarepta Therapeutics, Inc. | Conditions: Coronary Artery Disease, Coronary Restenosis | Phase 2 | Status: COMPLETED